Morning Briefing
Summaries of health policy coverage from major news organizations
Subsidiary Of Indian Drug Firm Pleads Guilty, Agrees To $500 Million Penalty
Ranbaxy USA admits to selling adulterated drugs and lying to regulators.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.